MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-CG-12-0003570
MSK Pharmaceuticals Private Limited
MSK Pharmaceuticals Private Limited - pharma in Saraipali, Chhattisgarh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹8.64 Cr
▲ 55% YoY
Net profit · FY 2025
₹4.09 Lakh
Net margin 0.5%
EBITDA · FY 2025
₹16.58 Lakh
EBITDA margin 1.9%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹20,000
Issued & subscribed
Open charges
₹75 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About MSK Pharmaceuticals Private Limited
Data last updated:
MSK Pharmaceuticals Private Limited is a private limited company based in Saraipali, Chhattisgarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U33119CT2020PTC010458. Its GSTIN is 22AANCM7236N1Z0 (Chattisgarh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹20,000. It is led by directors including Akshat Agrawal and Vipul Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khasra Number 788/4 Halka Number 14 Ward No.11 Padampur Road, Saraipali, Chhattisgarh, India – 493558.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.64 Cr, a growth of 55% compared to the previous year. For the same year it recorded a net profit of ₹4.09 Lakh (net margin 0.5%) and EBITDA of ₹16.58 Lakh (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 87% over three years.
As per MCA filings, the company has open charges of ₹75 Lakh on record.
MSK Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CG-12-0003570).
Company Details of MSK Pharmaceuticals Private Limited
CIN U33119CT2020PTC010458
Registration Number 010458
Incorporation Date 24 August 2020
ROC Chhattisgarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-CG-12-0003570
Recognitions & Rankings of MSK Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressKhasra Number 788/4 Halka Number 14 Ward No.11 Padampur Road, Saraipali, Chhattisgarh, India – 493558
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
MSK Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of MSK Pharmaceuticals Private Limited
The main business activity of MSK Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of MSK Pharmaceuticals Private Limited FY 2025 filings available
MSK Pharmaceuticals Private Limited reported revenue of ₹8.64 Cr (up 55% YoY) for FY 2025.
Revenue · FY 2025
₹8.64 Cr ▲ 55%
Net profit · FY 2025
₹4.09 Lakh margin 0.5%
EBITDA · FY 2025
₹16.58 Lakh margin 1.9%
Compounded Annual Growth Rate (CAGR) of MSK Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 55%
3 years · compounded
▲ 87%
EBITDA CAGR growth
1 year
▲ 54%
3 years · compounded
▲ 118%
Revenue has grown at a compounded annual rate (CAGR) of 87% over three years, including 55% growth in the latest year. EBITDA rose 54% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of MSK Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹16.58 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.09 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of MSK Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of MSK Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of MSK Pharmaceuticals Private Limited
MSK Pharmaceuticals has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akshat Agrawal | Director | 24 Aug 2020 | 6 Years 1 Months | Current |
| Vipul Agrawal | Director | 24 Aug 2020 | 6 Years 1 Months | Current |
| Pooja Agrawal | Director | 24 Aug 2020 | 6 Years 1 Months | Current |
Peer Comparison of MSK Pharmaceuticals Private Limited
MSK Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Favnox Pharmaceuticals Private Limited | ₹8.66 Cr (FY 2024) | •••• | •••• | 258.0% | •••• | Hyderabad, Telangana, India |
| Shanro Key Chem Industries Private Limited | ₹8.65 Cr (FY 2022) | •••• | •••• | -19.0% | •••• | Mumbai, Maharashtra, India |
| Harshan Pharma Private Limited | ₹8.65 Cr (FY 2024) | •••• | •••• | -87.0% | •••• | Hyderabad, Telangana, India |
| Shukan Colotex Chemestry Private Limited | ₹8.64 Cr (FY 2017) | •••• | •••• | 21.0% | •••• | Ahmedabad, Gujarat, India |
| Prajna Generics Private Limited | ₹8.64 Cr (FY 2022) | •••• | •••• | 3.0% | •••• | Telangana, India |
| MSK Pharmaceuticals Private Limited this company | ₹8.64 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | Saraipali, Chhattisgarh, India |
| Nansika Enterprises Private Limited | ₹8.63 Cr (FY 2025) | •••• | •••• | 2148.0% | •••• | New Delhi, Delhi, India |
| Kanad Labs Private Limited | ₹8.63 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Nagpur, Maharashtra, India |
| Urihk Pharmaceutical Private Limited | ₹8.62 Cr (FY 2025) | •••• | •••• | -19.0% | •••• | Mumbai, Maharashtra, India |
| Sameeksha Pharmaceuticals Private Limited | ₹8.61 Cr (FY 2024) | •••• | •••• | -91.0% | •••• | Pune, Maharashtra, India |
| Zahidi Pharmaceuticals Private Limited | ₹8.6 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Umbergaon, Gujarat, India |
Peers are the five companies nearest above and the five nearest below MSK Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of MSK Pharmaceuticals Private Limited
MSK Pharmaceuticals Private Limited is audited by Agrawal jain and Khemka for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Agrawal jain and Khemka | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of MSK Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of MSK Pharmaceuticals Private Limited
Open charges
₹75 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2022 | Idbi Bank Limited | ₹75 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at MSK Pharmaceuticals Private Limited
MSK Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on MSK Pharmaceuticals Private Limited
MSK Pharmaceuticals Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Akshat Agrawal was appointed as Director on 24 Aug 2020.
AGM
Msk Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Msk Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chhattisgarh.
Charges
A charge with Idbi Bank Limited of Rs. 75.00 Lakh registered on 28 Jun 2022 with Charge ID 100591855 was modified on 01 Dec 2023.
Charges
A charge with Idbi Bank Limited amounted to Rs. 75.00 Lakh with Charge ID 100591855 was registered on 28 Jun 2022.
Appointed
Akshat Agrawal was appointed as Director.
Appointed
Pooja Agrawal was appointed as Director.
Appointed
Vipul Agrawal was appointed as Director.
Incorporation
24 Aug 2020
Msk Pharmaceuticals Private Limited was registered on 24 Aug 2020 with Roc Chhattisgarh & aged 6 years 1 month as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for MSK Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by MSK Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of MSK Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of MSK Pharmaceuticals Private Limited
MSK Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AANCM7236N1Z0 | Chattisgarh | Active | 18 Dec 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of MSK Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MSK Pharmaceuticals Private Limited
MSK Pharmaceuticals is an active private limited company based in Saraipali, Chhattisgarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 August 2020 (6+ years old) and is registered under CIN U33119CT2020PTC010458.
MSK Pharmaceuticals reported revenue of ₹8.64 Cr for FY 2025 (up 55% YoY).
MSK Pharmaceuticals has 3 current directors:
- Akshat Agrawal - Director
- Vipul Agrawal - Director
- Pooja Agrawal - Director
MSK Pharmaceuticals reported a net profit of ₹4.09 Lakh (net margin 0.5%) and EBITDA of ₹16.58 Lakh (EBITDA margin 1.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of MSK Pharmaceuticals is 87% over three years. In the latest year (FY 2025) revenue rose 55%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of MSK Pharmaceuticals is 22AANCM7236N1Z0, registered in Chattisgarh.
The CIN (Corporate Identification Number) of MSK Pharmaceuticals is U33119CT2020PTC010458. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MSK Pharmaceuticals was incorporated on 24 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
The peers of MSK Pharmaceuticals by revenue are Favnox Pharmaceuticals Private Limited, Shanro Key Chem Industries Private Limited, Harshan Pharma Private Limited, Shukan Colotex Chemestry Private Limited, Prajna Generics Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Akshat Agrawal was appointed as Director on 24 Aug 2020. Pooja Agrawal was appointed as Director on 24 Aug 2020. Vipul Agrawal was appointed as Director on 24 Aug 2020.
Yes, MSK Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-CG-12-0003570).